Telehealth Insomnia Prescribing: What Psychiatrists Can Do in Michigan

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably wondered: Can I legally prescribe sleep medications remotely? What about controlled substances like Ambien? Do the rules differ by state?

The short answer: Yes, you can prescribe insomnia medications via telehealth in 2026 — including controlled substances like zolpidem and eszopiclone. But the details matter, especially if you’re practicing across multiple states or you’re a nurse practitioner navigating varying scope-of-practice laws.

Here’s what you need to know about prescribing insomnia medications via telehealth, how the rules differ for psychiatrists versus PMHNPs, and what the economic reality looks like for building a telepsychiatry practice focused on sleep disorders.

The Current Federal Landscape: Prescribing Controlled Sleep Meds via Telehealth

Most insomnia medications — zolpidem (Ambien), eszopiclone (Lunesta), temazepam, and others — are Schedule IV controlled substances. Historically, federal law (the Ryan Haight Act) required an in-person evaluation before prescribing any controlled substance via telemedicine.

COVID-19 changed that. The DEA suspended this requirement during the public health emergency, and those flexibilities have been extended through December 31, 2025, meaning they remain in effect as of early 2026. This allows psychiatrists and eligible PMHNPs to:

• Initiate controlled substance prescriptions via telehealth for new patients
• Continue refills for established patients
• Conduct the entire patient relationship remotely, without ever requiring an in-person visit

The catch? The DEA is expected to finalize permanent rules sometime in 2026. These may require periodic in-person visits for patients on long-term controlled substances, or introduce special telemedicine prescribing registrations. For now, though, the path is clear: if you’re properly licensed in the patient’s state and follow standard clinical protocols (comprehensive evaluation, informed consent, PDMP checks), you can prescribe insomnia medications via video visit.

What this means for your practice: You can see a Florida patient with chronic insomnia via video, diagnose primary insomnia, prescribe 30 days of zolpidem 10mg, and arrange a two-week follow-up — all without the patient stepping into an office. You’ll need to document thoroughly (patient location, consent for telehealth, clinical rationale) and use DEA-compliant e-prescribing, but the legal framework supports it.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs PMHNPs: Who Can Prescribe What, and Where?

Psychiatrists (MD/DO): Full Authority Everywhere

If you’re a board-certified psychiatrist, you have unrestricted prescribing authority for insomnia medications in all 50 states. Your scope includes:

• Full diagnostic evaluation (insomnia, comorbid psychiatric conditions, ruling out sleep apnea or restless legs syndrome)
• Prescribing any medication indicated — Schedule IV hypnotics, off-label trazodone or doxepin, benzodiazepines if anxiety is driving the insomnia
• Ordering sleep studies or coordinating with sleep medicine specialists
• Managing complex cases (insomnia secondary to PTSD, bipolar disorder with sleep disruption, etc.)

The only requirement: you must hold an active medical license in the state where the patient is physically located during the visit. If you’re in California treating a Texas patient via video, you need a Texas medical license. The Interstate Medical Licensure Compact (IMLC) makes this easier — Texas and Illinois are compact states, so psychiatrists can get expedited licensure there. California, New York, and Florida are not yet IMLC members, so you’ll need separate applications for those states.

No supervision required. No formulary restrictions. No day-supply limits beyond clinical judgment.

PMHNPs: It Depends on Your State

Psychiatric Mental Health Nurse Practitioners face a patchwork of regulations. Your prescribing authority for insomnia medications depends entirely on whether your state grants Full Practice Authority, Reduced Practice Authority, or Restricted Practice.

Full Practice States (Independent Practice)

As of 2026, 27 states plus DC allow experienced NPs to practice independently without physician oversight. In these states, a PMHNP can manage insomnia cases exactly like a psychiatrist — evaluate, diagnose, prescribe controlled substances, adjust treatment.

Key examples:

• New York: PMHNPs with 3,600+ clinical hours can practice completely independently. No collaborative agreement needed. You can open your own telepsychiatry practice, prescribe zolpidem or temazepam to your insomnia patients, and bill insurance directly. (Note: you must check the I-STOP PDMP for every controlled substance prescription — this is strictly enforced.)

• California: AB 890 created a pathway for independent NP practice. After working 3+ years as a ‘103 NP’ (in a physician group setting), you can become a ‘104 NP’ and practice solo within your psychiatric specialty. By 2026, many California PMHNPs have achieved this status. You can treat insomnia independently, prescribe Schedule IV meds, and operate a telehealth practice without MD supervision.

Reduced Practice States (Collaboration Required)

Some states require a collaborative agreement with a physician, but supervision is minimal and doesn’t involve day-to-day oversight.

• Illinois: New PMHNPs must have a collaborating physician and written agreement for prescriptive authority. However, after completing 4,000 clinical hours plus 250 CE hours in your specialty, you can apply for Full Practice Authority and prescribe independently (including controlled substances). Many Illinois PMHNPs treating insomnia have already made this transition — it’s a realistic 2-year pathway to autonomy.

Restricted Practice States (Significant Oversight)

Texas, Florida, and Pennsylvania impose the tightest restrictions. If you’re a PMHNP in these states, treating insomnia via telehealth requires more administrative lift.

• Texas: You must have a Prescriptive Authority Agreement with a Texas physician. The law requires monthly quality assurance meetings and periodic chart reviews. You can prescribe Schedule III-V drugs (including zolpidem) under delegation, but Schedule II controlled substances cannot be prescribed in outpatient settings at all. For insomnia, this isn’t a major issue — but it matters if you’re treating comorbid ADHD or narcolepsy.

• Florida: Psychiatric NPs were explicitly excluded from Florida’s 2020 law allowing some APRNs to practice autonomously. You need a supervising physician with a written protocol on file. Florida also limits NPs to a 7-day supply of Schedule II medications initially (though most insomnia meds are Schedule IV, so this rarely applies). If you’re treating a minor with insomnia, only a psychiatric APRN can prescribe controlled psychotropics — primary care NPs cannot.

• Pennsylvania: The most restrictive state on this list. You need collaborative agreements with two physicians, and state law limits you to prescribing no more than 90 days of Schedule III or IV medications without physician reevaluation. So if you start a Pennsylvania patient on Ambien via telehealth, after three months you’ll need your supervising physician to review and approve continuation. This adds workflow complexity and potentially slows care.

Bottom line for PMHNPs: If you’re in a full-practice state or on track to independent status (like Illinois), telehealth insomnia practice is nearly identical to a psychiatrist’s. If you’re in Texas, Florida, or Pennsylvania, you’ll need to secure physician oversight — which many telehealth platforms can help arrange, but it’s an operational requirement you can’t ignore.

State-Specific Telehealth Rules: Licensing, Registration, and Coverage

Beyond scope of practice, you need to understand each state’s telehealth infrastructure.

Licensure Requirements

You must be licensed in the state where the patient is located during the visit. Telemedicine doesn’t bypass state licensing. However:

• Florida allows out-of-state providers to register as telehealth practitioners without full licensure, provided you hold an active license elsewhere and meet eligibility criteria (no recent disciplinary actions). This streamlines serving Florida patients without the cost and time of full Florida licensure.

• Texas recently passed HB 1052 (effective January 2026), requiring insurers to cover telehealth services from providers licensed in Texas, even if the provider is physically located out-of-state during the visit. This doesn’t waive the license requirement, but it does clarify that Texas-licensed psychiatrists can deliver telehealth from anywhere.

• California, New York, Illinois, Pennsylvania require full in-state licensure for telehealth practice. No shortcuts. If you’re practicing in multiple states, budget for multiple license applications and maintenance fees (typically $200-500 per state annually).

Prescription Drug Monitoring Programs (PDMPs)

Nearly every state requires providers to check the state PDMP before prescribing controlled substances. This is a practical consideration for multi-state telehealth practice.

• Texas mandates PDMP checks for benzodiazepines and barbiturates
• New York requires I-STOP checks for every Schedule II-IV prescription — failure to check can result in board discipline
• California requires CURES checks every four months for ongoing controlled prescriptions

If you’re treating patients in five states, you’ll need access to five separate PDMP systems. Most are free to register, but it’s administrative overhead. Some telehealth platforms handle this through integrated EHR systems, but verify before you start.

Telehealth Reimbursement: Are You Getting Paid Fairly?

One of the biggest provider concerns: Will insurance pay the same for telehealth as in-person visits?

As of 2026, 24 states plus DC have enacted payment parity laws requiring private insurers to reimburse telehealth services at the same rate as face-to-face visits. This includes:

• California (longstanding parity since 1996)
• Illinois (permanent parity enacted 2021)
• New York (coverage parity plus de facto payment parity through network contracts)
• Texas (coverage parity; payment rates vary by insurer but trend toward parity)

Florida and Pennsylvania lack explicit payment parity mandates, but market dynamics and provider shortages mean most insurers reimburse telehealth competitively to retain network participation.

What does this mean in dollars? A 20-minute medication management visit for insomnia (CPT 99213) reimburses around $95 under Medicare’s 2026 fee schedule. A 30-minute visit (CPT 99214) pays approximately $125. Private insurance rates typically match or exceed Medicare, so expect $90-150 per visit depending on complexity and length — whether virtual or in-person.

Medicare continues to cover tele-mental health services nationwide, and Congress has repeatedly extended telehealth flexibilities. While there’s been discussion of requiring periodic in-person visits for long-term mental health telehealth patients, enforcement has been delayed and the political climate favors permanent telehealth coverage for psychiatry.

For a full-time telepsychiatrist conducting 20-25 patient visits per week at an average of $110 per visit, that’s $2,200-2,750 weekly revenue, or roughly $115,000-145,000 annually in collections. Subtract platform fees (if applicable), malpractice insurance (~$5,000-10,000/year for telehealth coverage), and overhead, and you’re looking at net income in the $100,000-130,000 range for a sustainable part-time telehealth practice. Scale to 40 patients weekly and you’re approaching or exceeding traditional practice income, with far lower overhead.

The Economics of Patient Acquisition: Why Platforms Make Sense

Here’s where many providers stumble: How do I actually get patients?

If you hang out your own shingle and try to market a telehealth insomnia practice yourself, you’ll quickly run into the cold reality of patient acquisition costs.

The True Cost of DIY Marketing

Let’s be honest about what it costs to acquire a qualified psychiatric patient through self-directed marketing:

• SEO (Search Engine Optimization): Building organic search traffic takes 6-12 months of consistent content creation, technical optimization, and backlink building. Most solo providers don’t have the expertise, and hiring an SEO consultant runs $1,500-3,000/month. Even then, you’re competing with established health systems and directory sites. It works eventually — but ‘eventually’ means burning cash for half a year before seeing meaningful patient flow.

• Google Ads: Mental health keywords are expensive. A click for ‘psychiatrist near me’ or ‘insomnia treatment online’ costs $15-40+. Most clicks don’t convert to booked appointments. Factor in ad spend, landing page optimization, A/B testing, and the staff time to follow up on leads (many of whom ghost or aren’t a good fit), and your cost per booked patient through PPC easily hits $200-400+. And that’s just to get them in the door once — retention is a separate challenge.

• Directory Listings: Psychology Today charges providers $29.95/month for a basic listing. You’re competing with hundreds of other providers on the same search results page. Zocdoc uses a pay-per-lead model (around $35-100+ per booked appointment, plus monthly subscription fees). It can work, but you’re paying every time whether the patient shows up or not — and no-show rates from cold directory leads run 20-30% in mental health.

Add it all up: a realistic all-in patient acquisition cost when you’re doing it yourself — considering agency fees, ad spend, staff time to qualify leads, no-shows, and opportunity cost — is $200-500+ per patient who actually completes an appointment.

And here’s the kicker: most solo providers don’t have the marketing budget or patience to sustain this long enough to see ROI.

The Platform Alternative: Pay for Performance

This is where a telehealth platform like Klarity Health changes the math.

Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. Klarity uses a pay-per-appointment model (similar to Zocdoc’s structure) with a standard listing fee per new patient lead. The value proposition is straightforward:

• Zero upfront marketing spend or monthly subscriptions. No retainer fees, no wasted ad dollars on clicks that don’t convert.
• Pre-qualified patients. These are people who’ve already been matched to your specialty (insomnia, anxiety, depression, ADHD, etc.) and your availability. They’re ready to book. No cold leads, no tire-kickers.
• Built-in telehealth infrastructure. No need to pay separately for a HIPAA-compliant video platform, EHR integration, or scheduling system. It’s included.
• Both insurance and cash-pay patient flow. You control which payors you accept. Klarity handles credentialing support and billing (if you want it), or you can manage insurance relationships yourself.
• You control your schedule. Set your availability, accept or decline patient requests, block time off. You’re not an employee — you’re running your practice through the platform’s patient acquisition engine.

The economic reality: A standard listing fee per booked patient is typically competitive with or below what you’d pay in true patient acquisition cost doing it yourself — and you have guaranteed ROI because you only pay when you actually see a patient. No risk of spending thousands on marketing campaigns that flop.

Think about it: if you’re paying a platform fee of, say, $40-60 per new patient appointment (hypothetically — actual fees vary), and you’re collecting $95-150 from insurance for that visit, you’re netting $35-110 per initial visit. On established patient follow-ups (which the platform doesn’t charge for), you’re keeping the full reimbursement. After 3-4 follow-ups with a typical insomnia patient (monthly check-ins over a quarter), you’ve made $400-600 in net revenue from that single acquired patient. Compare that to spending $300-500 acquiring them yourself with no guarantee they’ll stick around, and the platform model is a no-brainer.

For providers starting out or scaling up, this eliminates the risk entirely. You’re not betting the farm on whether your Google Ads will convert or your SEO will rank. You’re plugging into a patient pipeline that already exists.

What Insomnia Treatment Looks Like in Telehealth Practice

Insomnia is an ideal condition for telehealth, but it has unique clinical and workflow considerations.

Initial Evaluation (30-40 minutes)

Your first visit typically involves:

• Sleep history (onset, duration, patterns — many providers have patients complete a sleep diary or questionnaire beforehand)
• Rule-outs: depression, anxiety, substance use, medical conditions (thyroid, chronic pain), sleep apnea symptoms, restless legs syndrome
• Medication history (prior sleep meds, current prescriptions, OTC supplements)
• Setting expectations: Most guidelines recommend CBT-I (Cognitive Behavioral Therapy for Insomnia) as first-line treatment, with medication as adjunct or short-term option

You’ll bill this as a new patient visit (CPT 99204 or 99205 if high complexity), reimbursed at $165-210 depending on time and decision-making.

Prescribing Decisions

For pharmacotherapy, you’re typically choosing between:

• Non-benzodiazepine hypnotics: Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata) — Schedule IV, generally well-tolerated, FDA-approved for insomnia
• Low-dose sedating antidepressants: Trazodone 25-100mg, doxepin 3-6mg (off-label but commonly used, especially in patients with comorbid depression or anxiety about controlled substances)
• Melatonin receptor agonists: Ramelteon (Rozerem) — non-controlled, suitable for elderly or patients with substance use history
• Orexin receptor antagonists: Suvorexant (Belsomra), lemborexant (Dayvigo) — newer, non-controlled, but expensive and often require prior authorization

Best practice: Start with the lowest effective dose, schedule a 2-week follow-up to assess response and side effects, and emphasize sleep hygiene and CBT-I. Many patients expect a prescription immediately, but setting realistic expectations (medication is a bridge, not a permanent solution) improves long-term outcomes.

Follow-Up Care (15-20 minutes)

Most insomnia patients need 2-4 follow-ups in the first three months to dial in treatment. You’re checking:

• Sleep latency and duration improvement
• Side effects (next-day grogginess, complex sleep behaviors, tolerance)
• Concurrent behavioral interventions (sleep hygiene compliance, referral to CBT-I if not already done)
• Any need to adjust dose, switch medications, or initiate deprescribing

These visits bill as 99213 or 99214 (~$95-125 each). High retention patients — those who continue quarterly check-ins for ongoing medication — become the bread-and-butter of a sustainable telepsychiatry practice.

Coordinating Non-Pharmacological Care

One differentiator of excellent insomnia care: integrating CBT-I. You can:

• Refer to digital CBT-I programs (Somryst, Sleepio, or other FDA-cleared apps) — some insurers cover these
• Partner with therapists who specialize in sleep disorders
• Provide basic sleep hygiene education during med checks (limit screen time, consistent wake time, stimulus control techniques)

Why this matters: Guidelines universally recommend CBT-I as first-line or concurrent with medication. Providers who coordinate behavioral treatment see better patient outcomes and lower long-term medication dependence — which also reduces regulatory scrutiny around controlled substance prescribing.

State-by-State Snapshot: Where to Focus Your Telehealth Practice

If you’re considering multi-state telehealth, here’s how the priority states stack up for insomnia-focused practice.

California

Demand: High. Large population, tech-savvy patient base, underserved rural areas (Central Valley, Inland Empire). Strong employer-provided mental health benefits.
Provider Rules: Full practice pathway for experienced PMHNPs (104 NP status). Psychiatrists unrestricted.
Telehealth Environment: Telehealth parity law since 1996. Strong privacy regulations (CPRA) but platforms are compliant.
Bottom Line: Excellent market. High volume potential, supportive regulations, competitive reimbursement.

Texas

Demand: Very high. Rural provider shortages (West Texas, Panhandle), rapid population growth in metro areas (Houston, Dallas, Austin).
Provider Rules: Restricted NP practice (requires physician oversight). Psychiatrists fully independent. IMLC member (easy licensing for MDs).
Telehealth Environment: Telehealth coverage mandated; new 2026 law expands access. Payment parity trends positive.
Bottom Line: Great for psychiatrists. PMHNPs need platform support for supervising physician arrangement, but demand outstrips supply.

Florida

Demand: Very high. Large elderly population (insomnia common), historically low mental health access, long wait times for psychiatrists.
Provider Rules: PMHNPs excluded from autonomous practice — need supervising physician. Psychiatrists unrestricted.
Telehealth Environment: Out-of-state provider registration available. Coverage parity but not explicit payment parity.
Bottom Line: High opportunity state. South Florida has cash-pay culture; bilingual providers (Spanish) in high demand. Regulatory complexity for NPs.

New York

Demand: High. Huge urban market (NYC) plus underserved rural upstate areas. Academic centers and established telehealth adoption.
Provider Rules: Experienced PMHNPs (3,600+ hours) fully independent. New NPs need collaboration. Strict PDMP enforcement.
Telehealth Environment: Strong telehealth support, Medicaid covers audio-only for mental health, de facto payment parity.
Bottom Line: Favorable for both MDs and experienced NPs. Competitive in NYC, but upstate has unmet need.

Pennsylvania

Demand: High. Large mental health professional shortage areas (500,000+ residents in underserved areas), rural central/northern PA.
Provider Rules: Highly restricted NP practice (2 physician collaboration, 90-day limit on Schedule III/IV). Psychiatrists unrestricted.
Telehealth Environment: No mandated parity, but voluntary coverage common. IMLC member for MDs.
Bottom Line: Challenging for NPs, straightforward for psychiatrists. High need but regulatory burden for advanced practice.

Illinois

Demand: High. Chicago metro has providers but demand exceeds supply. Rural areas (southern/western IL) severely underserved.
Provider Rules: FPA pathway for NPs (4,000 hours + CE). New NPs need collaboration. Psychiatrists unrestricted. IMLC member.
Telehealth Environment: Permanent payment parity law (2021). Medicaid covers RPM and audio-only mental health.
Bottom Line: Excellent state. NP pathway to independence clear and achievable. Strong telehealth support, competitive market.

Practical Steps to Start Prescribing Insomnia Meds via Telehealth

1. Verify Your State Scope of Practice
Check your state board of medicine or nursing website for current prescriptive authority rules. If you’re a PMHNP in a restricted state, identify what oversight you need and whether a telehealth platform can provide it.

2. Secure Multi-State Licensure
Prioritize states with high demand and favorable regulations. Use the IMLC if you’re a physician and eligible states appeal to you. Budget 2-3 months and $1,000-1,500 per additional state license.

3. Register for State PDMPs
Complete registration in every state where you’ll prescribe controlled substances. Set up delegates if you have support staff handling Rx entry.

4. Ensure DEA-Compliant E-Prescribing
Use an e-prescribing platform that supports controlled substances (EPCS — Electronic Prescribing of Controlled Substances). Most modern EHRs include this, but verify.

5. Get Credentialed (If Accepting Insurance)
Credentialing takes 90-120 days with most insurers. If you’re joining a platform, ask if they handle credentialing or provide support. Prioritize high-volume payors in your target states (BCBS, Aetna, UnitedHealthcare, Medicare).

6. Build Clinical Protocols
Develop standardized intake forms (sleep questionnaires, PHQ-9 for depression screening), prescribing guidelines (start doses, follow-up intervals), and safety monitoring (PDMP checks, side effect documentation). Consistency protects you and improves patient outcomes.

7. Evaluate Platform vs. Solo Practice
If you’re established and have marketing budget, DIY can work long-term. If you’re starting out, scaling quickly, or practicing part-time alongside another job, a platform eliminates patient acquisition risk and accelerates revenue.

FAQ: Insomnia Prescribing via Telehealth

Can I prescribe Ambien (zolpidem) to a new patient I’ve never seen in person?
Yes, as of 2026, federal rules allow prescribing Schedule IV controlled substances (including zolpidem) via telehealth without a prior in-person visit. This flexibility is extended through December 31, 2025, and expected to continue in some form. You must conduct a proper clinical evaluation via video, document thoroughly, and comply with state PDMP requirements.

Do PMHNPs have the same prescribing authority as psychiatrists?
It depends on your state. In full-practice states (like New York for experienced NPs, or California after achieving 104 NP status), yes — you can prescribe insomnia medications independently. In restricted states (Texas, Florida, Pennsylvania), you need physician oversight and may face additional limitations (like Pennsylvania’s 90-day limit on Schedule III/IV prescriptions).

What if my patient needs a sleep study to rule out sleep apnea?
You can order a home sleep apnea test (HSAT) remotely, or refer the patient to a local sleep medicine specialist or pulmonologist for in-lab polysomnography if clinically indicated. Many patients with insomnia have comorbid sleep apnea, so screening (with tools like the STOP-BANG questionnaire) is best practice. You continue medication management while they pursue diagnostic workup.

How do I avoid regulatory trouble with controlled substance prescribing?
Follow these safeguards: (1) Check the state PDMP before every new controlled Rx and periodically for ongoing prescriptions. (2) Document clinical rationale (why this medication, why this dose, risks/benefits discussed). (3) Set clear follow-up intervals (don’t prescribe 90 days of zolpidem without a check-in). (4) Use informed consent specific to controlled substances if your state requires it. (5) Avoid prescribing to patients who exhibit drug-seeking behavior or have concerning PDMP findings without appropriate consultation.

Can I treat insomnia patients in multiple states simultaneously?
Yes, if you hold active licenses in each state. You must follow each state’s telehealth and prescribing rules. For example, if you’re licensed in both Texas and Illinois, you can treat Texas patients (with physician oversight for your prescribing if you’re an NP) and Illinois patients (independently if you have FPA in Illinois). Most telehealth platforms allow you to set which states you’re available in based on your licensing.

Is telehealth reimbursement for insomnia treatment sustainable long-term?
Yes. States are moving toward permanent telehealth coverage and payment parity. Medicare continues to cover tele-mental health. The political and market momentum favors telehealth expansion, not contraction. While specific policies may evolve, the direction is clear: telehealth for psychiatric care (including insomnia) is here to stay and will remain financially viable.

What happens when DEA finalizes new controlled substance prescribing rules?
The DEA is expected to issue permanent telemedicine prescribing regulations in 2026. Likely requirements will include either periodic in-person evaluations (perhaps annually) for patients on long-term controlled substances, or special telemedicine DEA registrations. Most telehealth providers are preparing by establishing partnerships with local clinics for in-person visits if needed, or structuring practices to comply with whatever rules emerge. Stay subscribed to DEA updates and platform communications — compliance will be manageable, just potentially more administrative.

Why Insomnia Care via Telehealth Is the Right Move Right Now

The demand for psychiatric services has never been higher. Insomnia is one of the most common complaints — affecting up to 30% of adults — and it’s underdiagnosed and undertreated in traditional practice settings.

Telehealth removes the barriers: no commute for patients, flexible scheduling (evening appointments are easy), and lower overhead for providers. The regulatory environment is as favorable as it’s been, with controlled substance prescribing flexibilities and payment parity laws in place.

If you’ve been on the fence about telepsychiatry, or you’re looking to expand your practice into a new specialty, insomnia is a smart entry point. The clinical care is straightforward, the patient volume is there, and the economics work — especially when you’re not burning cash on patient acquisition and instead letting a proven platform deliver qualified patients to you.

Whether you’re a psychiatrist with full prescribing authority everywhere, or a PMHNP navigating state-by-state scope differences, there’s a clear path to building a sustainable, rewarding telehealth practice focused on helping people sleep better.

And if you’re looking for a way to do that without the marketing headaches, operational complexity, and financial risk of going solo — that’s exactly what Klarity Health was built for.

Sources and References

1. California Board of Registered Nursing – AB 890 Implementation (rn.ca.gov/practice/ab890.shtml) – Updated 2024. Official state board guidance on NP independent practice categories (103/104 NP).

2. Texas Medical Board – Prescribing and Supervision FAQs (tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision) – Current as of 2019 law, accessed Feb 2026. Outlines TX requirements for APRN prescriptive authority agreements and Schedule II limitations.

3. Florida Nurse Practitioner Association – Legislative Talking Points (flanp.org/page/TalkingPoints) – 2023. Details Florida’s 7-day controlled substance limits and psych NP exclusion from autonomous practice law.

4. Rivkin Radler Law Blog – New Law Allows Experienced NPs to Practice Independently in NY (rivkinrounds.com, April 13, 2022) – Confirms New York’s 3,600-hour threshold for independent NP practice.

5. Commonwealth Foundation – Nurse Practitioner Reform: Full Practice Authority in Pennsylvania (commonwealthfoundation.org, Dec 5, 2022) – Policy report detailing PA’s restrictive NP rules including 2-physician collaboration and 30/90-day controlled substance limits.

6. NursePractitionerLicense.com – Illinois Practice Limitations (nursepractitionerlicense.com, Feb 12, 2024) – Summarizes Illinois NP collaborative requirements and pathway to Full Practice Authority (4,000 hours + CE).

7. USA Doctor Network – How to Get Insomnia Prescriptions via Telemedicine (usadocnetwork.com, June 11, 2025) – Outlines DEA’s extension of telemedicine prescribing flexibilities through December 31, 2025.

8. Center for Connected Health Policy – State Telehealth Laws and Reimbursement Policies Report, Fall 2025 (cchpca.org, Oct 2025) – Comprehensive 50-state telehealth law summary including payment parity data (24 states) and Texas HB 1052 coverage expansion.

9. Medicare Physician Fee Schedule – MedFeeSchedule.com (medfeeschedule.com, effective Jan 1, 2026) – National average reimbursement data for CPT codes 99213 (~$95) and 99214 (~$125).

10. NPSchools.com – Guide to NP Practice in Florida (npschools.com/blog/guide-to-np-practice-in-florida) – Reviewed 2026. Confirms Florida HB 607 exclusion of psychiatric NPs from autonomous practice provisions.

Ready to start treating insomnia patients via telehealth without the patient acquisition headaches? Join Klarity Health’s provider network and get matched with pre-qualified patients in your licensed states — with zero upfront marketing costs and full control over your schedule. Learn more about joining Klarity →

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025